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IN THE PAST 2 decades, orthotopic liver transplantation (OLT) has become a standard treatment for end-stage liver disease. In the United States, the number of liver transplantations performed more than doubled from 2201 in 1989 to 4700 in 1999. 1 Improvements in surgical technique, organ preservation, immunosuppression, and management of complications have increased 1-year patient survival from 30% in 1980 to approximately 80% in 1997. [1] [2] [3] These improvements have also reduced postsurgical infection rates and, more importantly, reduced the mortality associated with infections. 4 However, infectious complications remain a substantial problem after OLT. [5] [6] [7] Liver transplant recipients are particularly susceptible to infection. The surgical procedure itself is complex and can take many hours, even in the best of hands, and has the potential for contamination via the gastrointestinal tract. 5, [8] [9] [10] Immunosuppression not only increases susceptibility to infection but also masks the inflammatory response, making early detection more challenging. 11 In recent studies, infection rates after liver transplantation between 50% and 70% have been reported. [12] [13] [14] [15] [16] Mortality due to infection, however, has declined from >50% before 1980 to <10% in the 1990s. 4 The effect of surgical site infections on outcomes and resource utilization after liver transplantation
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Epidemiologic aspects of postsurgical infections have been described in the literature. The most frequently occurring infections are bacterial and fungal infections of the operative site, including the wound, abdomen, and organ space. 10, 13, 16, 17 Bacterial infections tend to occur earliest, most commonly during the first 4 to 6 weeks after transplantation. 14 Fungal infections also appear early, within the first 8 weeks after transplantation. 14 Several risk factors for posttransplantation infections have been identified in the literature. Patients with prolonged pretransplantation hospitalization, 12 low pretransplantation hemoglobin levels, 12 low serum albumin levels, 5 high pretransplantation bilirubin levels, 7, 12, 17 renal insufficiency, 5 and those who had previous transplantation 13, 16, 18 are more likely to develop postsurgical infections. Surgical risk factors include leaks in the biliary anastomosis, 14, 19 duration of surgical procedure, 16, 17 and the amount of blood products transfused, particularly packed red blood cells. 7, 16, 20, 21 Posttransplantation risk factors include the use of OKT3 13, 19 and acute rejection, 12 which are clearly related.
Although risk factors for infection and the implications of infection for clinical outcomes have been described, less is known about the economic implications of postsurgical infections. Liver transplantation is one of the most costly procedures performed in the United States, and infections are one of the most devastating complications. 2, 22, 23 To our knowledge, the excess costs associated with surgical site infections after OLT have not been quantified. In addition to risk factors contributing to surgical site infections, this study estimates the additional burden imposed by surgical site infections after OLT on mortality, graft survival, length of hospital stay, and excess costs from 3 transplant centers in the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database.
METHODS
Patients. The NIDDK Liver Transplantation Database contains information from a 7-year prospective study of 1563 liver transplant candidates, including 916 orthotopic liver transplant recipients who received transplants between 1990 and 1995 from 1 of 3 centers (Mayo Clinic, University of Nebraska Medical Center, and University of California San Francisco Medical Center). 2, 24 This database was designed to study the demographics, clinical characteristics, and outcomes of patients undergoing OLT. 25 We initially selected 868 first transplantations from the 916 total transplants in the database. An additional 91 patients were excluded because of missing age and birth date information (n = 53) or missing followup information (n = 16) or because they received another organ during the transplant procedure (n = 25). Our final sample included 777 first, singleorgan, liver transplant recipients. Of these patients, 292 developed a surgical site infection within 1 year after transplantation. The patients were studied to find the risk of infection and graft survival. The surgical site infection occurred during the transplant hospitalization in 159 of the 292 patients with infections. Resource utilization was studied in this subset of patients.
Surgical site infections. Surgical site infections were defined according to guidelines from the Centers for Disease Control and Prevention. 26 According to this definition, surgical site infections include deep and superficial incisional infections and organ and organ space infections that occur within 1 year of the surgical procedure. Organ and organ space infections include any part of the body that is opened or manipulated during the operative procedure. In addition, there must be purulent drainage from a drain placed through a stab wound to the organ space; organisms isolated from a culture of the fluid or tissue in the organ space; an abscess or other evidence of infection found on direct examination, during reoperation, or by histopathologic or radiologic examination; or diagnosis of surgical site infection by a surgeon or attending physician.
Infections were recorded in the Liver Transplantation Database if they were identified by positive culture and treated on the basis of culture findings. We defined surgical site infections as bacterial or fungal infections of the liver, intestine, biliary tract, surgical wound, or peritoneum that occurred within 1 year of transplantation. These infections represent the most common infections 
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after OLT and are similar in terms of risk factors, prophylaxis, and treatment.
Resource utilization. Information on charges was not part of the original data collection strategy but was added to the NIDDK Liver Transplantation Database in 1994 to allow research regarding resource utilization issues. Standardization was required to make resource utilization comparable across 3 institutions and 6 years. This was achieved by compiling a list of all services provided to each transplant recipient taken from detailed billing records for the first transplant received. The 1995 prices for each of the services from just 1 of the 3 institutions were then applied to the list of services. 27 Professional fees were not included in these prices. 2 Thus, resource utilization represents the hospital charges that patients would have incurred for their transplant admission had they received their transplant at the index institution in 1995. 2 Because resource utilization data were only collected for hospitalization of the first transplant procedure, we studied resource utilization with 159 patients whose infections occurred during the initial transplant hospitalization.
Statistical methods.
Univariate and multivariate analyses were performed (1) to identify pretransplant, surgical, and posttransplant variables that were significantly associated with surgical site infections, (2) to estimate the impact of surgical site infections on graft survival and mortality, and (3) to estimate the excess length of stay and charges associated with surgical site infections. Univariate comparisons were made by using the Student t test for continuous variables and the Fisher exact test for binary variables. Risk factors for infection were identified with logistic regression. Variables included in the model were those that have been identified as predictors of infection in the literature. Patient and graft survival were estimated with the Kaplan-Meier product limit estimate and differences were tested with the log rank test. 28 Excess resource utilization was defined as excess charges and extended length of stay. Differences in length of stay were compared with Student t test. Differences in charges were also compared with Student t test and multiple linear regression to control for other factors that may increase costs. All analyses were performed with SAS statistical soft- 
RESULTS
Demographics. As shown in Table I , chronic hepatitis, cholestatic liver disease, and alcoholic liver disease accounted for approximately 81% of diagnoses for referral for transplantation. Most pediatric patients (n = 77) underwent OLT for biliary atresia (55.8%). Demographic and clinical characteristics of the patients are reported in Table  II and suggest that patients who developed surgical site infections after liver transplantation were similar in terms of ethnicity (P = .99), but the proportion of males (P = .02) and younger patients as higher (P = .04). Patients with infections also had similar pretransplant clinical and laboratory characteristics, including obesity (P = .48), renal failure (P = .89), hematocrit (P = .80), and total bilirubin levels (P = .31). A higher proportion of patients with infections had ascites (P = .001) and a longer pretransplant hospital stay (P = .001). In terms of transplant and surgical characteristics, patients with infections had similar numbers of HLA-A and HLA-B loci mismatches (P = .386) and proportions of choledochocholedochostomy biliary anastomoses (P = .600). In contrast, they also had significantly longer cold ischemia time (P = .04), longer operation duration (P = .001), and more blood products transfused (P = .002). They were also more likely to receive OKT3 during the first week after transplantation (P = .02).
Pathology of infections. From the 777 patients with transplants studied, 292 developed 705 surgical site infections (2.4 per patient on average). The most common surgical site infections, described in Table III , occurred in the biliary tract (32.1%). These infections were predominantly bacterial, with Enterococcus species identified as the most common infecting agent (26.1%), and occurred approximately 11 weeks after transplantation. Peritoneal and wound infections were the next most common surgical site infections and accounted for approximately 45% of infections. The predominant organisms cultured at these sites were coagulase-negative staphylococci and staphylococcus aureus, respectively. These were the earliest infections, occurring at approximately 5 to 6 weeks after transplantation. Fifteen percent of surgical site infections occurred in the bowel. Although these 
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infections were predominantly bacterial (82.2%), intestinal infection had the highest proportion of fungal infections (17.8%) and occurred approximately 10 weeks after transplantation. As might be expected, Clostridium species were by far the dominant organism associated with intestinal infections (71%). Liver infections accounted for only 7.4% of surgical site infections and occurred at 10 weeks after transplantation. Like biliary infections, the organisms most frequently cultured from liver infections were Enterococcus species.
Risk factors for surgical site infection. Modeling risk for infection, we identified several significant pretransplantation and surgical predictors for surgical site infections (Table IV) . The most important predictors of infection were leaks in the biliary anastomosis. A choledochojejunostomy anastomotic leak increased risk of infection by 7 times (P = .0001), whereas a choledochocholedochostomy leak increased risk by 2.5 times (P = .007). Operation duration also increased risk of infection, with each additional hour of surgical procedure increasing risk by 19% (P = .002). These risk factors suggest the importance of surgical technique and duration of the procedure in avoiding posttransplant infections. Several pretransplant patient characteristics were also important predictors of infection. Patients with ascites were 43% more like- utable to surgical site infections to $131,276 (P = .0001). Surgical site infections had the largest impact on resource utilization of any variable studied.
DISCUSSION
Preoperative infections are significant sources of morbidity, mortality, and resource utilization among orthotopic liver transplant recipients. 5, 6, [29] [30] [31] In this study of 777 first, single organ transplant recipients from the NIDDK Liver Transplantation Database, we found that transplant recipients who develop surgical site infections had a significantly higher rate of graft loss, accumulated more than 24 additional hospital days, and incurred approximately $131,000 in excess charges. As noted previously, these excess charges represent 1995 dollars. The medical care component of the Consumer Price Index rose approximately 18.3% between 1995 and 2000. Inflating excess charges by this amount suggests that the excess charges attributable to surgical site infections may be as high as $155,269 today.
Our findings, with respect to risk factors for infection, are similar to previous reports in the literature. Pretransplant ascites and low serum albumin levels have been previously suggested as risk factors for infection. 5, 12 Others have also found factors relating to surgical technique, including leaks in the biliary anastomosis and duration of surgical procedure, and use of OKT3 to be significant predictors of infection. 7, 13, 14, 16, 19 Our finding that patients with surgical site infections do not experience significantly higher rates of mortality but do have higher rates of graft loss was also suggested by Whiting et al. 13 Multivariate analysis of charges suggested that each HLA-A, and HLA-B mismatch was associated with $13,504 in excess charges. Although rejection episodes may explain this phenomenon, it is
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Hollenbeak, Alfrey, and Souba 393 Volume 130, Number 2 ly to develop a surgical site infection (P = .037), and low levels of serum albumin in grams per deciliters were associated with a 41% greater risk of infection (P = .009). Patients who received OKT3 in the first postoperative week were approximately 50% more likely to develop a surgical site infection (P = .039), which suggests the important relationship between acute rejection and infection. Other factors studied, including pediatric transplant recipients, female sex, ethnicity, volume of packed red blood cells, and cold ischemia time did not significantly affect the likelihood of surgical site infection.
Patient and graft survival. One-year patient and graft survival were estimated with the method of Kaplan and Meier. 28 Death with a functioning graft was considered a graft loss. Although the 1-year survival rate for patients with infections was slightly lower than that for patients without infections (88.9% vs 91.8%), the difference was not statistically significant (P = .22; Fig 1) . The graft survival rate, however, was significantly lower for patients with surgical site infections (80% vs 87%, P = .018).
Resource utilization. As noted previously, 292 patients developed surgical site infections. However, only 159 patients developed surgical site infection during the transplant admission. These 159 patients had significantly higher resource utilization requirements than patients who did not develop surgical site infections during the transplant hospitalization. Patients who developed surgical site infections incurred on average, unadjusted for other factors, $159,975 in additional charges ($337,409 vs $177,433; P = .0001) and 24 additional hospital days (47 vs 23; P = .0001) compared with uninfected transplant recipients. Note that infections did not concentrate resource use in any single department but significantly increased costs throughout all cost centers (P < .01 for all cost centers; Fig 2) .
Results from a multivariate analysis of costs are presented in Table V and show that although surgical site infections were not the only factor that contributed to increased resource utilization, they were the most costly. Severity, determined by the Karnofsky scale, increased charges by nearly $11,000 per index point (P = .0002). Packed whole red blood cells increased charges by $9727 (P < .0001) per 1000 mL unit. Each additional hour of cold ischemia time resulted in an additional $1656 (P = .021) in charges, and each HLA-A or -B mismatch cost $13,504 (P = .037). Finally, patients with edema incurred, on average, $24,763 in additional charges (P = .041). Race and sex were not significantly associated with increased charges. Controlling for these other factors reduced the estimate of excess costs attrib- unlikely that rejection episodes account for all of this difference. In analyses not reported here, we found that HLA antigen mismatches were not significant predictors of rejection episodes, nor were rejection episodes significant predictors of charges. Although the NIDDK Liver Transplantation Database is an excellent resource for studying outcomes and resource utilization in liver transplantation, several weaknesses in this study derived from its use. First, the transplantations occurred between 6 and 11 years ago, and there have been rapid advancements in surgical technique and antibiotic, antifungal, and antiviral prophylaxis since the time the data were collected. There were no details regarding antibiotic prophylaxis or selective bowel decontamination before transplantation.
Another limitation is the level of detail for classification of infections. The NIDDK Liver Transplantation Database recorded the site, cultured organism, and dates of infections. Although this reasonably allowed us to identify surgical site infections according to the Centers for Disease Control and Prevention standard, there may be some infections that have been unspecified. For example, it is possible that some infections of the bowel were antibiotic-associated colitis and not necessarily infections caused by leaks in the anastomosis or manipulation during surgical procedures.
There are also limitations to the use of charges instead of costs as a proxy for resource utilization. 32 Although charges are a reasonable proxy for resource utilization, they may also overstate the impact of adverse events on actual costs. On the other hand, charges do not include other costs that may be important to an economic analysis. Charges also represented total charges for the entire transplant hospitalization. Although pretransplant length of stay was not a significant predictor of infection when other factors were controlled, patients who later developed surgical site infections stayed, on average, 6.0 days before transplantation compared with 3.7 days for patients who did not develop surgical site infections (P = .055). The average charge per day for patients with surgical site infections was $7751. To account for the pretransplant stay, $17,827 may be subtracted from our estimate of excess charges.
Other important infections were not studied, most notably cytomegalovirus (CMV). 33 Previous studies have shown that CMV infections are significant predictors of charges. 34 Because strategies for preventing and treating CMV infections are very different from those for surgical site infections, we have maintained a narrow focus in the hope of providing more valuable input to decisions regarding prevention of the most common infections.
Because clinical outcomes have improved for OLT, issues of cost and cost-effectiveness have become more important. Our results suggest that each surgical-site infection that was prevented translates into approximately $131,000 in charges avoided. This implies that substantial resources could be devoted to preventing infections and that there are potentially substantial returns to preventative efforts directed at surgical site infections after OLT.
